Inhibition of matrix metalloproteinase activity attenuates tenascin-C production and calcification of implanted purified elastin in rats.
about
Biocompatibility of a xenogenic elastin-based biomaterial in a murine implantation model: the role of aluminum chloride pretreatment.Genetics in arterial calcification: pieces of a puzzle and cogs in a wheel.MMP-9 inhibitor SB-3CT attenuates behavioral impairments and hippocampal loss after traumatic brain injury in rat.Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinasesCross-sectional relations of arterial stiffness, pressure pulsatility, wave reflection, and arterial calcification.Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis.Alteration of vaginal elastin metabolism in women with pelvic organ prolapseTriglycidylamine crosslinking of porcine aortic valve cusps or bovine pericardium results in improved biocompatibility, biomechanics, and calcification resistance: chemical and biological mechanisms.Elastin calcification in the rat subdermal model is accompanied by up-regulation of degradative and osteogenic cellular responsesAdvances in tenascin-C biology.Unified theory on the pathogenesis of Randall's plaques and plugsMechanisms of the in vivo inhibition of calcification of bioprosthetic porcine aortic valve cusps and aortic wall with triglycidylamine/mercapto bisphosphonate.Aluminum chloride pretreatment of elastin inhibits elastolysis by matrix metalloproteinases and leads to inhibition of elastin-oriented calcification.Osteogenic responses in fibroblasts activated by elastin degradation products and transforming growth factor-beta1: role of myofibroblasts in vascular calcificationPrevention of calcification in bioprosthetic heart valves: challenges and perspectives.New evidence for a critical role of elastin in calcification of native heart valves: immunohistochemical and ultrastructural study with literature review.Chronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications.In vivo cellular repopulation of tubular elastin scaffolds mediated by basic fibroblast growth factor.Regulation of valvular interstitial cell calcification by components of the extracellular matrix.Biomechanical and biologic effects of meniscus stabilization using triglycidyl amine.How do stones form? Is unification of theories on stone formation possible?Weight loss-induced calciphylaxis: potential role of matrix metalloproteinases.The Involvement of miR-29b-3p in Arterial Calcification by Targeting Matrix Metalloproteinase-2.Increased proliferation and adhesion properties of human dental pulp stem cells in PLGA scaffolds via simulated microgravity.Shrinkage temperature and anti-calcification property of triglycidylamine-crosslinked autologous tissue.
P2860
Q30758854-1D871E7B-CFD3-46C3-B3A6-377BD9875949Q33352008-C2657BC9-07FA-4D53-9ED8-8A8D059246A3Q33847555-5C399136-9761-4E59-A68B-CF8B1EC31634Q34092968-AC927A91-FB04-47B9-ABD4-7D7D30BF90B1Q34353330-3BCDA1DC-5A43-432A-B314-6E0ED23DFEFFQ34454068-D4D748FB-34B1-4B03-9F51-DDD3800F65F5Q34591815-26F6FAE0-8CDD-413C-8B5D-F60985EA37B5Q35083543-99FF7787-6528-47BE-B05B-EFA5DE1AA40FQ35087914-26CC0526-42E5-4930-861A-21D7507985A0Q35214557-10CE6799-BC10-4A61-AC52-35655D38C159Q35216521-4829EEA2-4676-43D4-BCC2-9908FAF51DCDQ35691445-C7DE17DF-2E74-44CC-893C-3D473031F0E7Q35747196-59E51C2D-C52B-4BD2-8F26-5C8EEE5323AAQ35928260-29317B76-B5C7-4060-925D-552B2EF270B4Q35967307-925F7D20-CACF-419D-8050-F962FDC6ED49Q37950408-AA754C6E-7743-4F57-BC2C-162F796CD640Q38016491-76A893F2-00E0-4721-A088-29886B293122Q42132181-19D83F24-834F-45F8-B9BA-A9A394C69B6EQ43003872-AB95AE73-6269-4B82-9C76-2B5E464F44DDQ45951438-10C5073F-E814-414E-81A1-18AEAC766911Q46414748-A8A0A50A-8B3B-44D6-BB43-5E4E382E80A2Q47431137-55DF2D6B-3E7F-4A64-83FE-566D8A43EFBAQ48275190-E9AC35AA-5E68-4E98-96DA-7EBAB464D680Q53308315-64B1740E-E141-4A05-9A74-C08E2533567FQ53559920-FAAEC6AF-8623-468A-95C3-27732239D356
P2860
Inhibition of matrix metalloproteinase activity attenuates tenascin-C production and calcification of implanted purified elastin in rats.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Inhibition of matrix metallopr ...... nted purified elastin in rats.
@ast
Inhibition of matrix metallopr ...... nted purified elastin in rats.
@en
type
label
Inhibition of matrix metallopr ...... nted purified elastin in rats.
@ast
Inhibition of matrix metallopr ...... nted purified elastin in rats.
@en
prefLabel
Inhibition of matrix metallopr ...... nted purified elastin in rats.
@ast
Inhibition of matrix metallopr ...... nted purified elastin in rats.
@en
P2093
P2860
P1476
Inhibition of matrix metallopr ...... nted purified elastin in rats.
@en
P2093
N Vyavahare
S Tallapragada
P2860
P304
P356
10.1016/S0002-9440(10)64602-0
P407
P577
2000-09-01T00:00:00Z